Induction and Evaluation of Autoimmune Encephalomyelitis
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Brigham and Women's Hospital
Other organizations : Stanford University, Broad Institute, Dana-Farber Cancer Institute
Variable analysis
- Immunization with 100μg MOG 35–55, MOG 1–125 or NP18-OVA emulsified 1:1 with H37RA Mtb and CFA
- Administration of 200μg anti-PD-L2 (clone 3.2) on d2 and d4
- Induction of EAE with emulsion containing extra 2mg/ml H37RA Mtb and 200ng pertussis toxin i.p. on days 0 and 2
- Draining lymph node or blood harvested for analysis 7 days after immunization
- Clinical disease assessed using a 5-point scale (1 = limp tail, 2 = weak gait, 3 = hind limb paralysis, 4 = hind+forelimb paralysis, 5 = moribund)
- Mice were immunized as previously described(25)
- Positive control: None specified
- Negative control: None specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!